Health2Sync and Novo Nordisk Pharma Korea, Ltd. Launch Smart Cap Mallya® for FlexTouch® Insulin Pens Integration in South Korea, Enhancing insulin administration via Digital Diabetes Care
SEOUL, SOUTH KOREA - Media OutReach Newswire - 9 July 2025 - Health2Sync, Asia's leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for FlexTouch® Insulin Pens data into SugarGenie, its Korean-market diabetes management app. Mallya® enables automatic recording of insulin injection details. This data can be synced directly into a patient's digital health record and shared with healthcare providers via SugarGenie, HealthSync's solution in Korea.This innovation comes at a critical moment. Managing insulin administration records is a challenging task for both diabetes patients and healthcare professionals. In fact, a multinational survey of diabetes patients receiving insulin treatment and physicians treating diabetes patients found that 27.6% of patients experience difficulty administering insulin at the prescribed time or with meals. In the same study, 54.5% of physicians reported that their patients experience difficulty administering insulin at the prescribed time or with meals.Mallya®, when paired with Health2Sync's connected ecosystem, significantly lowers this burden. Patients using FlexTouch® insulin pens can now have their dosage, time, and frequency data recorded and visualized in real time within the SugarGenie app."This integration is connecting yet another integral part in digital diabetes care," said Ed Deng, CEO and Co-founder of Health2Sync. "By connecting the data of Mallya® to SugarGenie, we're improving accuracy in insulin tracking and expanding the depth of data available to patients and care teams. Our platform enables insulin logs to be viewed alongside blood glucose, meals, and physical activity, offering a full circle understanding of each patient's health context."Deng continued: "For healthcare professionals, this means faster, smarter decisions. Our care provider portal lets clinicians view real-time patient data We're turning disconnected data points into a unified, actionable picture of care, without placing additional burden on patients."SugarGenie's integration with Mallya® supports remote care models and automated record-keeping—an increasingly critical combination for long-term chronic condition management in South Korea. With its clean interface, real-time sync, and care team dashboard, SugarGenie is a key digital infrastructure in Korea's diabetes treatment landscape."Digital healthcare has become a key tool in enhancing the efficiency and convenience of diabetes treatment," said Kasper Roseeuw Poulsen, General Manager of Novo Nordisk Pharma Korea, Ltd.. "For over a century, Novo Nordisk has supported patients through holistic solutions, and our collaboration with Health2Sync is also a continuation of that commitment. We hope this strategic collaboration will help create a more systematic and efficient treatment environment for both patients and healthcare professionals in Korea."Hashtag: #health2sync #diabetesmanagement #digitaltherapeutis #digitalhealth
The issuer is solely responsible for the content of this announcement.
Health2Sync
Founded in 2013, Health2Sync is a leading digital health company in Asia focused on delivering personalized and comprehensive solutions for chronic disease management. Its core offerings include a mobile patient app and a cloud-based analytics platform for healthcare providers, designed to drive measurable improvements in blood glucose outcomes.
With the most extensive clinical network in Asia, Health2Sync offers a scalable, data-driven approach to diabetes care. The platform empowers patients with tailored insights, enabling healthcare professionals and caregivers to support them remotely and fostering continuous, collaborative care throughout the entire treatment journey.
For more information, please visit https://www.health2sync.com/ko.
About SugarGenie App
Health2Sync's SugarGenie app collects biometric information measured by medical devices and transmits it to a platform via encrypted protocols, allowing patient data to be shared with family, caregivers, and healthcare institutions.5 It integrates data such as blood glucose level, blood pressure, weight, and user-inputted dietary and exercise information. It transforms it into visual reports to provide personalized feedback, enable effective communication between patients and healthcare professionals, and monitor real-time health status. As of June 2025, Health2Sync has over 1.5 million users worldwide.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
7 hours ago
- Malay Mail
Health Ministry struggles to cope with chronic underfunding — Chan Chee Khoon
JULY 18 — Speaking at a public forum in Kuala Lumpur in 2023, a senior officer from Ministry of Health's (MOH) planning division denigrated the UK National Health Service as a poor example to emulate given its current sad state. Unfortunately, he seemed unaware of how the NHS had been ravaged in the preceding decades by both Tory as well as Labour governments, and what lessons MOH could draw from that decline (given the shared legacy of our Bevan–Beveridge institutional architectures). Just as we shouldn't unduly blame NHS for the service failures emanating from its subjection to an 'internal market' regime, we shouldn't blame MOH for its desperate resort to RakanKKM to monetise its (contested) inpatient spare capacity for supplementary revenues. Without supplemental taxes and substantial increases in federal allocations, MOH is desperately trying to cope with chronic underfunding by spawning a 'private' non-profit subsidiary. This was envisaged to generate some margins beyond cost recovery, from user charges for medium-cost services provided on a priority basis, by physicians of choice. The supplementary earnings were intended as cross-subsidies for MOH's regular patients, as well as incentives for MOH staff retention. Citizens' Health Initiative would like to offer a context and narrative that weaves together various strands in the continuing public discourse following the recent hikes in health insurance premiums. We do not present this necessarily as the unfolding of a premeditated strategy. It is more a descriptive chronology of contingent circumstances that nonetheless interacted in a manner that is gradually re-balancing the system towards healthcare provided on the basis of ability to pay, rather than on the basis of need. Why Malaysia needs to double its public sector healthcare spending Our post-Merdeka improvements in life expectancies at birth were internationally acclaimed, all the more remarkable given our very modest government healthcare expenditures (rarely exceeding 2 per cent GDP). The Rural Health Service's initiatives in village midwifery (bidan kampung), vaccine-preventable childhood ailments, tandas curah ('Jitra bowl'), the Applied Food and Nutrition Programme (AFNP), potable water supply, and control of communicable diseases were very well-chosen low-cost interventions which markedly reduced mortality among young children and mothers. Commendable increases in life expectancy at birth however mask a much less satisfactory trend in life expectancy in late adulthood, in comparison with Singapore, Taiwan, Hong Kong and other developed countries in the Asia-Pacific region: This poor adult life expectancy largely reflects Malaysia's burgeoning epidemics of Non-Communicable Diseases (NCDs), along with the highest prevalence in Southeast Asia of risk factors like obesity and being overweight. Meanwhile, the prevalence of diabetes mellitus had almost tripled from 6.3 per cent in 1986 to 11.6 per cent in 2006 to 17.5 per cent in 2015 (Yap et al, 2019; Safurah Jaafar et al, 2013). Malaysia's well-distributed primary healthcare system might have performed well for acute, episodic, self-limiting diseases in our early decades, but we are currently in new territory amidst escalating epidemics of NCDs. This epidemiological-cum-demographic transition requires multi-sectoral promotive as well as comprehensive primary health care, and the commensurate financial, staffing, and material resources to deliver it. We should not be captive to historical health budgeting practices whose modest annual increments are no longer adequate for the scale of effort that is now required—the prevention, detection, and oftentimes lifelong treatment of NCDs, with referral linkages and continuity of care at multiple levels, provided in a timely manner at adequately staffed and equipped facilities. Chronic underfunding of Health Ministry has obliged many Malaysians to prepare for contingencies – Picture by Raymond Manuel MOH's chronic underfunding At a public forum in September 2019, Tan Sri (Dr) Abu Bakar Suleiman (DG Health, 1991–2001) attributed the chronic underfunding to a developmental strategy premised on large inflows of FDI attracted through competitive lowering of corporate and income tax rates, which hobbled the fiscal capacity of states. This however was not the sole reason for MOH's chronic underfunding. There was concurrently active encouragement of for-profit healthcare, with tax incentives and subsidies, to cater to 'market-capable' segments of society. Tun Dr Mahathir Mohamad (PM 1981–2003) unwisely chose not to expand the public sector to meet increasing healthcare needs, preferring instead to allow space for the rapid growth of for-profit healthcare. Seductive logic of targeting Faced with this chronic underfunding, a succession of health ministers argued that Malaysians who could afford it should patronise the private sector (suitably encouraged thus with income tax rebates) so that the government could conserve its modest resources for the 'truly deserving poor'. This intuitively appealing rhetoric of targeting will more likely hasten the arrival of a two-tier healthcare system of deluxe priority care for the rich, and a rump, underfunded public sector for the rest. RakanKKM to the rescue of market failures? Chronic underfunding of MOH has obliged many Malaysians to prepare for contingencies they will likely face when seeking urgently needed inpatient care at congested public hospitals. For those without deep pockets, such contingency plans invariably look to commercial hospitals and the requisite insurance coverage for urgent critical care if and when its need arises. When large segments of the 'market-capable' middle class get entangled however in a tug-of-war between profit-driven health providers and profit-driven health insurers, the government is compelled to intervene, in this case with a 'premium economy' option RakanKKM in publicly owned hospitals. It is far from clear that MOH has enough spare capacity to scale up proof-of-concept trials to cater to policy holders abandoning unaffordable premiums. This could exacerbate existing backlogs of regular MOH patients even as neighbouring Singapore is aggressively recruiting Malaysian doctors and nurses for their own envisaged non-profit MOH hospitals. Unkept promises and a proposed Tabung Kesihatan Negara Meanwhile the Madani government continues to ignore electoral promises and calls for increased allocations and expanded capacity for publicly provided healthcare. This would require a dedicated ring-fenced Tabung Kesihatan Negara which could be funded by a supplementary progressive health tax, corporate taxes, property and capital gains taxes, Tobin-type taxes, 'sin' taxes, (zakat?), with credible stakeholder representation, accountability, and transparency. This however seems to be off the radar screen currently, hobbled in part by public scepticism over the stewardship of public financial resources. Will the Madani government live up to its name, or will we need to elect a government which keeps electoral promises, and which we can trust with the management of public monies? * This is the personal opinion of the writer or publication and does not necessarily represent the views of Malay Mail.
Malay Mail
a day ago
- Malay Mail
Cockroaches and contaminated chicken: Caterer fined S$7,000 over mass food poisoning incident at ByteDance's Singapore office
SINGAPORE, July 17 — Catering company Yunhaiyao, which operates the Yun Nans restaurant chain, was fined S$7,000 (RM23,123) today for its role in a mass food poisoning incident that sickened 171 people at ByteDance's Singapore office last year, Channel News Asia reported. The fine was imposed for two offences: one under the Environmental Public Health (Food Hygiene) Regulations and another under the Sale of Food Act. Appearing in court to receive the sentence on behalf of the company, Yunhaiyao chief executive officer Lu Zhi Tao listened as District Judge Janet Wang called the number of victims 'staggering' and said it was fortunate no deaths occurred. The court heard that the affected individuals had consumed a wok-fried diced chicken dish catered by Yunhaiyao on July 30, 2024 that contained dangerously high levels of staphylococcus aureus — a bacterium known to cause foodborne illness. Laboratory testing by the Singapore Food Agency (SFA) found the bacteria count in a food sample exceeded 200,000 colony-forming units per gram, far above the legal limit of 100 units. SFA prosecutor Mohd Rizal told the court that 60 of the 171 victims were taken to hospital. While 38 of them were treated as outpatients or self-medicated, 22 were hospitalised for between one and three days. According to Channel News Asia, the SFA also found more than 10 live cockroaches during an inspection of the Yun Nans outlet at Northpoint City following the incident. Yunhaiyao had earlier pleaded guilty to both charges. The first was for failing to maintain food hygiene standards, as evidenced by the cockroach infestation. The second was for selling food "not of the quality demanded by ByteDance", given the excessive staph contamination in the chicken dish. Staphylococcus aureus can produce toxins in food when it's not properly cooked or stored, or when it is handled by individuals with poor hygiene. The prosecution had sought a combined fine of S$5,500, noting this was the company's first offence. However, Judge Wang imposed a slightly higher fine of S$7,000, citing the serious health consequences for a large number of people.
Malay Mail
a day ago
- Malay Mail
The invisible club — Nahrizul Adib Kadri
I'm often told I look normal. In fact, when I sit in the waiting room of the neuro clinic for my annual check-up, I might even look like I'm there for someone else. I dress neatly. I walk in unaided. I respond when my name is called. There's no oxygen tank by my side, no slurred speech, no visible signs that something once went deeply wrong. But I'm the patient. I'm the one with a brainstem cavernoma — a rare malformation tucked deep inside the pons, where vital things live: breathing, swallowing, balance, vision. Mine was discovered almost by accident in late 2015 after a year of quiet, persistent numbness. No real pain. Just a strange tingling on the left side of my body — like when your leg falls asleep. Except this one didn't wake up. Even after diagnosis, I felt mostly fine. Until I didn't. On my 41st birthday, after a small slice of cake, I vomited. Just once. But I remembered what my neurosurgeon had said: If anything changes, head straight to emergency. So I did. What followed was a slow spiral — days in a hospital room, my vision narrowing, my head heavy as stone. They drilled a hole in my skull to relieve the pressure. And when things didn't improve, they opened it properly. They removed the cavernoma. And with it, a part of the person I used to be. The surgery was a success. Technically. The mass was gone, but the aftermath lingered. I emerged with right-side facial paralysis and fine motor loss in my left hand. I couldn't use a straw to drink. I couldn't button a shirt with my left hand. I couldn't pronounce the consonants F, V, B, or M without sounding like I was underwater. These were not headline-worthy losses. No one made a documentary about it. But they changed my daily rhythm in subtle ways. And now, almost a decade later, they still do. In the neuro clinic, I'm often the most 'normal-looking' person in the room. There's a cruel kind of irony to that. Some patients shuffle in, others are wheeled. Some can't speak. Others don't respond. Then there's me — smiling halfway, speaking carefully, nodding with one side of my face. And because I pass, people assume I'm fine. That I've recovered. That the story is over. But recovery doesn't always mean return. Sometimes it means reinvention. I'm not who I was. But I'm someone still becoming. We live in a world obsessed with how things appear — with symmetry, vitality, performance. And we admire recovery when it ends in a triumphant 'after.' What we don't talk about is the middle. That long, awkward middle where you're not who you were, and not yet sure who you'll be. It's in that space I've quietly learned how to live again — how to laugh when others flinch at my half-smile, how to teach when my words won't form the way they used to, how to type research papers when my fingers fumble the home keys. Haruki Murakami once wrote, 'Pain is inevitable. Suffering is optional.' It's the kind of quote that looks great on a poster, but feels slippery in practice. Pain can change you long before you choose how to respond to it. And sometimes, just waking up and carrying on is the only choice you have. Murakami's characters often walk through surreal landscapes of loss and disorientation, not to escape their pain but to better understand it. I think about that often — how we don't really get out of the woods, we just learn to walk differently within them. I like to think there's a quiet club for people like me. We don't meet. We don't speak of it. But we recognise each other — in the slightly delayed grip of a handshake, in the gentle sway of someone regaining balance, in the pause before a word that's harder to pronounce than it used to be. Coelho once wrote, 'The strongest love is the love that can demonstrate its fragility.' Maybe the same can be said for strength itself. Real strength isn't loud. It doesn't announce its victories. It adapts. It hums quietly beneath the surface of ordinary things: holding a pen, buttoning a cuff, walking into a clinic with your head held just high enough. Over time, you learn to stop explaining yourself. People will think you're fine, and you let them. Not because you owe them silence, but because you've made peace with being misread. When someone asks me if I'm fully recovered, I say, 'I'm well.' And I mean it. I'm well in ways that matter. I teach, I research, I write. I raise three sons with a woman who knew me before all this. I show up. I adapt. I live. But once a year, when I sit in that neuro clinic — surrounded by wheelchairs, soft-spoken nurses, and a neurosurgeon who never forget my face — I remember that I belong to a quiet category. Not the visibly broken. Not the visibly healed. Just quietly altered. And maybe that's the mark I carry now — not the scar at the back of my head, not the asymmetry of my smile, but the quiet knowledge that looking normal and being fine are not the same thing. Not even close. * Ir Dr Nahrizul Adib Kadri is a professor of biomedical engineering at the Faculty of Engineering, and the Principal of Ibnu Sina Residential College, Universiti Malaya. He may be reached at [email protected]. ** This is the personal opinion of the writer or publication and does not necessarily represent the views of Malay Mail.
